Dr L. Syd M Johnson joins Ethics Talk to discuss her article, coauthored with Drs Hope Ferdowsian and Jessica Pierce: “How One Health Instrumentalizes Nonhuman Animals.”
Developing drugs for profit is challenged in Parasites!, a patient education comic that highlights the need for unprofitable drugs for tropical diseases.
AMA J Ethics. 2018;20(2):167-175. doi:
10.1001/journalofethics.2018.20.2.msoc1-1802.
As physicians we decide which tests or treatments go on the bill but have little idea how our decisions impact what patients pay. Now patients, payers, and policymakers are demanding that we consider the cost of our recommendations.
This process of developing EBM-based guidelines and applying them to clinical care highlights the tension between generating unbiased knowledge based on statistical aggregation and the application of this information to individual patients.
AMA Journal of Ethics editor Audiey Kao, MD, PhD, interviewed Richard Pan, MD, MPH, about how, as a physician and legislator, he seeks to protect public health in light of recurrent outbreaks of vaccine-preventable infectious diseases.
Wejdan Bagais joins Ethics Talk to discuss her article, coauthored with Matt Christian: “Which Data Analytics Tool Should We Use to Evaluate Risk in Upstream Drug Supply Chains?”